GH

GH EBITDA Margin

-34.76%TTM

Period ending:

GH FY EBITDA Margin%
GH FY EBITDA Margin-11.11%-171.67%
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

GH ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Guardant Health Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-38.0753%
-52.7892%
-76.8342%
-136.7871%
-96.2449%
-78.4965%
-26.65%
-83.6704%
-151.0894%
-156.1329%

Compare ebitda margin

All GH financial metrics · GH stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.